| Jill H Olson Moser, OTR/L | |
|
401 Phalen Blvd, Saint Paul, MN 55130-5302 | |
| (651) 254-3200 | |
| (651) 254-7710 |
| Full Name | Jill H Olson Moser |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 401 Phalen Blvd, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912632274 | NPI | - | NPPES |
| Provider Name | Park Nicollet Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
By 2031, the number of Ontarians living with eye disease and vision problems, already in the millions, is expected to double. This leads to significant costs for Ontario's healthcare system, with vision loss already costing the province $7.3 billion annually.
Early-stage lung and prostate cancers as well as their recurrence can be detected with a simple blood test, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 1 days ago
| Provider Name | Regions Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154359917 PECOS PAC ID: 3173436755 Enrollment ID: O20031110000511 |
News Archive
By 2031, the number of Ontarians living with eye disease and vision problems, already in the millions, is expected to double. This leads to significant costs for Ontario's healthcare system, with vision loss already costing the province $7.3 billion annually.
Early-stage lung and prostate cancers as well as their recurrence can be detected with a simple blood test, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 1 days ago
| Provider Name | Tria Orthopaedic Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
By 2031, the number of Ontarians living with eye disease and vision problems, already in the millions, is expected to double. This leads to significant costs for Ontario's healthcare system, with vision loss already costing the province $7.3 billion annually.
Early-stage lung and prostate cancers as well as their recurrence can be detected with a simple blood test, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill H Olson Moser, OTR/L 8170 33rd Ave S, Ms 21110q, Bloomington, MN 55425-4516 Ph: () - | Jill H Olson Moser, OTR/L 401 Phalen Blvd, Saint Paul, MN 55130-5302 Ph: (651) 254-3200 |
News Archive
By 2031, the number of Ontarians living with eye disease and vision problems, already in the millions, is expected to double. This leads to significant costs for Ontario's healthcare system, with vision loss already costing the province $7.3 billion annually.
Early-stage lung and prostate cancers as well as their recurrence can be detected with a simple blood test, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 1 days ago
Ann E. Richter, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 University Ave W, Suite 10, Saint Paul, MN 55104 Phone: 651-999-1035 | |
Mrs. Lacey Maier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-5540 | |
Kimberly R Pritchett, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 280 Smith Ave N Ste 500, Saint Paul, MN 55102 Phone: 651-968-5420 Fax: 651-222-0956 | |
Barbara Johnson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 709 University Ave W, Saint Paul, MN 55104 Phone: 651-227-8471 | |
Lauren Eleise Dusek, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 333 Smith Ave N, Saint Paul, MN 55102 Phone: 651-241-8000 | |
Rebecca Jo Binder Marturano, OTR/L. Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1394 Jackson St, Saint Paul, MN 55117 Phone: 651-603-8774 | |
Cynthia L Wagner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 310 Smith Ave N Ste 370, Saint Paul, MN 55102 Phone: 651-223-5406 Fax: 651-287-3777 |